UBS AG - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 64 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 4.15 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS AG ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2014$22,000
-45.0%
4,377
+49.6%
0.00%
Q2 2014$40,000
-95.5%
2,925
-94.9%
0.00%
-100.0%
Q1 2014$887,000
+4827.8%
57,908
+2388.5%
0.00%
Q4 2013$18,000
+5.9%
2,327
+37.0%
0.00%
Q3 2013$17,000
+750.0%
1,698
+307.2%
0.00%
Q2 2013$2,0004170.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 169,578$222,0000.08%
Geneos Wealth Management Inc. 478,067$626,0000.03%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$16,0000.01%
Atria Wealth Solutions, Inc. 281,700$369,0000.01%
Vivaldi Capital Management LP 17,078$22,0000.01%
OSAIC HOLDINGS, INC. 1,284,481$1,684,0000.00%
Ameritas Advisory Services, LLC 45,302$59,0000.00%
CENTAURUS FINANCIAL, INC. 20,947$27,0000.00%
Summit Trail Advisors, LLC 23,855$31,0000.00%
WEDBUSH SECURITIES INC 27,998$37,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders